Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

drug dose, dose, pharmacogenomics, Personalized medicine

Many Americans take medications that are ineffective or cause adverse reactions due to genetic differences in drug metabolism. Pharmacogenomics, the study of how genes affect drug response, can help tailor medications to individual genetic profiles, reducing trial and error in prescriptions. A s…

Sep 27^th • 1 min read

The evolving landscape of precision medicine in primary liver cancer

liver cancer, personalized care, precision medicine

The field of oncology and cancer research is changing. As our understanding of the underlying biology of the disease improves, the one-size-fits-all treatment model has been exposed as inadequate. PLC is among the hardest to treat malignancies and as such carries one of the worst prognoses. While th…

Mar 29^th • 3 mins read

Medical affairs: The power behind redefining commercialization

Medical affairs commercialization, integrating science in pharma, redefining medical affairs roles, strategic medical affairs leadership, early engagement with payers, pharmaceutical commercialization strategies, upskilling in medical affairs, medical aff

In March 2024, Envision Pharma Group held a Medical Affairs Professional Society (MAPS) Americas roundtable with leaders discussing the role of science in commercialization strategies and the importance of integrating robust scientific understanding into the commercial journey. Envision revisite…

Aug 2^nd • 3 mins read